conference paper · IOP Conference Series Materials Science and Engineering
Abstract Effective management of haemostatic disorders in patients is pertinent in order to prevent complications attributable to incidences of thrombosis in atherosclerotic arteries to the heart, brain, limbs, stagnant blood in veins and heart chambers. The use of existing chemical agents are not without a number of challenges, varying from potential for unknown long-term adverse effect through lack of antidote for most agents, balance between cost and efficacy among others. However, advent of biogenic silver nanoparticles with anticoagulant and thrombolytic potentials has opened up a window of opportunity to address most of the shortcomings of the chemical synthesized anticoagulants. This review examined green synthesized novel silver nanoparticles, their characterization and possible application as anticoagulant and thrombolytic agents in the evolving area of nanomedicine.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1088/1757-899x/805/1/012043
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
